IRVINE, Calif. – May 2, 2017 – AIVITA Biomedical today announced that it will be appearing at the upcoming Music City SCALE Symposium for Cosmetic Advances & Laser Education in Nashville, Tennessee. The conference, taking place May 4-7 at the Nashville Music City Convention Center, will educate physicians on the latest developments in medical and aesthetic skin care with a focus on laser and technology-based procedures.

“Arguably the first major innovation since retinols, our new topical skin care line complements other novel procedures being discussed at this forward-thinking conference,” said Dr. Hans S. Keirstead, CEO of AIVITA. “We are excited to be featured at and sponsor such an important symposium.”

AIVITA’s proprietary anti-aging technology, the active ingredient in its PROVOQUE® line of physician-only skin care products, will be highlighted in a presentation by conference co-chair Michael Gold, M.D. in Saturday’s Cosmeceuticals and Skin Care track. AIVITA will also be demonstrating and selling its skin care products in the conference exhibit hall, offering several promotional discounts to attending physicians and the opportunity to speak with senior research staff who developed the product.

The Music City Scale Symposium is a 4-day conference which will cover a range of topics including the treatment of acne, psoriasis, light based technologies, Energy Based Devices (EBDs), injectables, topical skin care and more.

“It is a great opportunity for us to bring our groundbreaking product line to such an esteemed group of physicians and medical skin care professionals,” said Chris Harper, Director of Sales at AIVITA.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline. All proceeds from the sale of PROVOQUE^® directly support AIVITA’s Phase 2 clinical trial for the treatment of ovarian cancer.

###